Pressmeddelanden, rapporter och bolagsmeddelande för Hamlet BioPharma B
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Press release from Companies: Invitation to monthly digital events and presentations of quarterly reports
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Press release from Companies: Hamlet BioPharma, det innovativa läkemedelsbolaget, med en stark portfölj av projekt för behandling av cancer och infektioner, meddelar uppdatering kring pågående kliniska studier
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Press release from Companies: Hamlet BioPharma, the innovative pharmaceutical company, with a strong portfolio of projects, for the treatment of cancer and infections, is featured in this weekend issue of The Guardian
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Press release from Companies: Hamlet BioPharma Participates in The Global Forum 2024
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Reports: Q3 Interim Report January - March 2024
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Press release from Companies: Hamlet BioPharma bjuder in till investerarträff
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Press release from Companies: Clinical data from patients with bladder pain syndrome support anakinra (IL1-RA) as a new, successful treatment option
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Press release from Companies: Hamlet BioPharma secures large scale Alpha1 peptide production in an agreement with Polypeptide Group
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Press release from Companies: Alpha1H to be the first asset for the commercial collaboration
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Press release from Companies: Immune responses in patients treated with Alpha1H - results published in the journal Cancer Medicine